Merck KGaA (ETR:MRK) Trading 0.5% Higher – Still a Buy?

Shares of Merck KGaA (ETR:MRK) traded up 0.5% during mid-day trading on Thursday . The stock traded as high as €118.40 and last traded at €117.15. 292,655 shares traded hands during trading, The stock had previously closed at €116.55.

Merck KGaA Stock Performance

The company has a current ratio of 1.46, a quick ratio of 0.72 and a debt-to-equity ratio of 41.86. The firm has a market capitalization of $52.77 billion, a price-to-earnings ratio of 19.47, a price-to-earnings-growth ratio of 2.37 and a beta of 0.72. The company has a 50-day moving average of €115.65 and a 200-day moving average of €117.89.

Merck KGaA Company Profile

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector. This segment provides drug manufacturers with process development expertise and technologies, such as continuous bioprocessing; testing kits and services; reagents and services; testing solutions that analyze air, water, and soil; and testing and tools, as well as products that help test nutritional value and identify quality inconsistencies.